Post-IPO Equity Health Diagnostics Companies

4DMedical is a global medical technology company, revolutionizing respiratory imaging and ventilation analysis for lung diseases.

Lumos Diagnostics provides point-of-care diagnostic solutions enabling healthcare professionals to diagnose conditions accurately.

Qlife is a Danish medical technology company that develops an innovative medical technology platform.

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.

Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

BioSenic is a forward-thinking firm that aims to address critical unmet medical needs.

LumiraDx is a healthcare company that manufactures a diagnostic platform to support a menu of tests with lab comparable performance.

Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.

CMT focuses on the development and commercialization of regenerative therapies derived from novel processed human platelets.

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

Intelligent Bio Solutions leverages the power of technology to develop transformative, accurate solutions that improve quality of life.

Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.

Personalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine.

Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

Atlantic Coastal Acquisition Corp. II is a blank check company.

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders

Cognetivity Neurosciences is a Platform technology for early, rapid and easy detection of dementia.

Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.